InsiderTrades

BIOS Fund II QP, LP

SEC CIK 1716869 · EDGAR

Buying vs selling by month open-market trades, last 50 months, all 3 companies
BoughtSold

Companies

TickerCompanyTitleHoldingBoughtSoldTradesFirstLast
LTRNLantern Pharma Inc.10% 189.1K — $123.6K 12025-06-132025-06-13
ACTUACTUATE THERAPEUTICS, INC.Dir, 10% 61.9K $4.00M $225.0K 42024-08-142024-08-14
INABIN8BIO, INC.Dir, 10% 559.1K $103.3K — 12022-08-262022-08-26

Most active insiders at LTRN, 12 months

#InsiderTitleBoughtSold
1 Schalop Lee TroyDir $100.0K—
2 KEYSER D JEFFREYDir $100.0K—

BIOS Fund II QP, LP made no open-market trades at LTRN in the last 12 months.

Transactions 6

Type
Reset
X Filed Traded Ticker Company Insider Title Type Price Qty Owned ΔOwn Value
MI 2025-06-13 2025-06-13 LTRN Lantern Pharma Inc. BIOS Fund II QP, LP 10% S - Sale $3.09 -40.0K 189.1K -17% -$123.6K
DMI 2024-08-14 2024-08-14 ACTU ACTUATE THERAPEUTICS, INC. BIOS Fund II QP, LP Dir, 10% C - Cnv Deriv — +9.38M 61.9K New —
DMI 2024-08-14 2024-08-14 ACTU ACTUATE THERAPEUTICS, INC. BIOS Fund II QP, LP Dir, 10% X - OptEx $5.27 +38.0K 133.6K +40% +$200.0K
DMI 2024-08-14 2024-08-14 ACTU ACTUATE THERAPEUTICS, INC. BIOS Fund II QP, LP Dir, 10% S - Sale+OE $9.00 -25.0K 131.2K -16% -$225.0K
DMI 2024-08-14 2024-08-14 ACTU ACTUATE THERAPEUTICS, INC. BIOS Fund II QP, LP Dir, 10% P - Purchase $8.00 +500.0K 125.0K New +$4.00M
MI 2022-08-30 2022-08-26+ INAB IN8BIO, INC. BIOS Fund II QP, LP Dir, 10% P - Purchase $2.02 +51.2K 559.1K +10% +$103.3K

Purchase Sale Sale after option exercise All abbreviations